Studies suggest the prevalence of deficiency in the UK is one in 10 people aged 75 and over, one in 20 aged 65-74, and lower in younger age groups except for vegans, where prevalence is around 11%
What the research does not yet prove Large-scale human clinical trials are lacking for most regenerative peptides
Some of these pharmacy clinics dont require a doctors order or a preliminary blood test, making the process very simple
For individuals with active cancer, recent cancer history, or significant cancer risk factors, discussing peptide use with an oncologist is advisable
BPC-157 vs TB-500 Key Differences in Research BPC-157 and TB-500 are two of the most widely studied peptides in laboratory research involving tissue repair, cellular signalling, and regenerative processes